Conference abstractPublished 2018
The MBL2 gene polymorphisms and serum mannose-binding lectin (MBL) concentration/activity in patients suffering from haematological malignancies, treated with autologous haematopoietic stem cells transplantations
Polish Academy of Sciences, Poland Copernicus Memorial Hospital in Lodz Comprehensive Cancer Center and Traumatology, Poland Cancer Center and Institute of Oncology, Poland Medical University of Lodz, Poland Institute of Hemato
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A prospective study of patients suffering from multiple myeloma (n=194) and lymphomas (n=118), who received high-dose conditioning chemotherapy and autologous haematopoietic stem cell transplantation (auto-HSCT) was conducted. Polymorphisms of MBL2 gene were investigated and serial measurements of serum concentration of mannose-binding lectin (MBL) were made. Serum samples were taken before conditioning chemotherapy, before HSCT and once weekly after (totally 4-5 samples); in minority of subjects also one and/or three months post transplantation. The results were compared with data from healthy controls (n=267) and analysed in relation to clinical data to explore possible associations with cancer and with chemotherapy-induced medical complications. We found a higher frequency of MBL deficiency-associated genotypes (LXA/O or O/O) among multiple myeloma patients compared with controls. It was however not associated with hospital infections or post- HSCT recovery of leukocytes, but seemed to be associated with the most severe infections during follow-up. The first possible association of MBL2 gene 3’-untranslated region polymorphism with cancer (lymphoma) in Caucasians was noted. Conditioning chemotherapy induced significant increase in serum MBL concentration (as well as MBLdependent complement activity), prolonged for several weeks. Our data suggest that, in the context of chemotherapy of myeloma and lymphoma, MBL has little influence on infection during the short period of chemotherapy-induced neutropenia, but could have a protective effect when able to act in combination with phagocytic cells after their recovery.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Forensic Toxicology & Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Maciej Cedzynski”
- BylineArticles whose byline prints “Anna S Swierzko”
- BylineArticles whose byline prints “Mateusz Michalski”
- BylineArticles whose byline prints “Anna Sokolowska”
- BylineArticles whose byline prints “Mateusz Nowicki”
- BylineArticles whose byline prints “Lukasz Eppa”
- BylineArticles whose byline prints “Agnieszka Szala-Pozdziej”
- BylineArticles whose byline prints “Iwona Mitrus”
